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Failure to visualize or correctly visualize sentinel nodes
(SN) during preoperative lymphoscintigraphy (LS) is a
frustrating problem. Most of these instances occur due to
inexperience in performing the studies, and can be real-
ized and corrected with the use of proper technique, even
in centers that do not have state of art equipment. This is
now becoming a major issue, as more and more sentinel
node biopsies are being performed, and will increasingly
gain more importance once sentinel lymph node biopsy
(SLNB) becomes the standard of care in patients with
breast cancer world wide.
Pandey et al. [1] has recently reported two unfortunate
experiences with LS during SLNB. From the images and
the description of the cases, it appears that the studies
were suboptimal in both imaging and injection tech-
nique, and understandably, completely frustrating to any
surgeon.
In the second case, contamination of the patient by stray
radioactivity from the perilesional injections is suggested
by the authors as the cause of the superior focus that
appeared in the supracalvicular region [1]. Actually, true
contamination is very easy to realize with proper imaging
technique [2-4]. When multiple angled views (0°, 45°,
90°) are obtained, including standing/sitting views and
triangulated body marking (TBM), contamination is
extremely unlikely to be missed, as it is always surface
based. In over 2000 LS cases we have performed, the very
rare stray activity has always been picked up for what it is,
before the patient is presented to the surgeons [2-4].
In the first case, a SN was hidden by the injected perile-
sional activity [1]. This is a known issue when the primary
lesion is located near the axilla itself. Multiple strategies
exist for dealing with diffusion and scatter from the injec-
tion site hiding the adjacent SNs in the axilla, and are
described below:
1) When performing perilesional injections of radiotracer,
multiple angled views and standing views, which use grav-
ity to markedly shift the injected activity inferiorly and
medially away from the axillary SN compared to the
supine position, are indispensable [3,4]. In addition, the
perilesional injections should be on the side of the lesion
away from the axilla to further lessen diffusion of activity
from the injection site from obliterating the SN [3].
2) The volume of perilesional injections should be
reduced when injecting close to the axilla to lessen diffu-
sion and inherent scatter of activity (maintain below 3
ml) [3].
3) Upwardly offset energy windows can be used in the
camera to reduce "relative" scatter in the images to help
better see the SNs [2-4].
4) Proper image display techniques are critical; the images
presented for the first case [1] appear to display subopti-
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mal adjustment as related to upper level, contrast/
gamma/threshold. Proper adjustment parameters are cru-
cial for the delineation of a faint SN adjacent to intense
activity from the injection site [4].
5) Yet, finally, an even better solution to the complexities
of upper outer quadrant lesions, is to shift part or all of the
injected dose to the areolar region [3-5]. This will largely
or completely resolve the issues of injected activity/diffu-
sion/scatter hiding a closely approximated SN in the axilla
[3-5]. In addition, An Adaptive Injection Technique (AIT)
can be employed to allow a limited control over the
number of echelon nodes realized, and improve overall
SN intensity. High injection volumes (0.8–1.0 ml) admin-
istered over 1–2 minutes at the "areolar-cutaneous junc-
tion", referred to by us as LymphoBoost (LB), tend to nearly
always delineate SNs (96.6%–100%) [4-6], and often
multiple distant echelon nodes [3-7]. This is because these
very shallow LB injections are extremely efficient at deliv-
ering activity to the SN compared to perilesional intra-
parenchymal injections, and even intradermal over the
lesion injections [3-7]. Compared to concurrently admin-
istered perilesional and intradermal over the lesion injec-
tions, LB areolar injections, and other areolar type
injections in general, delineate essentially the same pri-
mary nodes (excluding internal mammary nodes [3,5,6])
in the vast majority of patients, and do so with several
times the efficiency of getting activity into the SN [3-7].
The LB areolar injections occasionally depict additional
nodes closer to the injection site, the "reverse echelon node"
(REN), a feature of areolar type injections in general
related to injection location [3,5,8]. They also delineate
additional conventional echelon nodes compared to per-
ilesional injections [3,5-7]. There is preliminary evidence
that low injection volumes (0.1–0.3 ml) at the areolar-
cutaneous junction tend to delineate fewer echelon nodes
(which could be viewed as advantageous by some), and
also result in fainter nodes, compared to high injection
volumes (0.6–1.0 ml) [[5], (data pending publication)].
In addition, low injection volumes are also more prone to
failure in delineating the SNs on LS as evidenced by a low
78.5% SN visualization rate during LS in a recent study by
Rousseau et al. [9] when using very low volume 0.1 ml
injections of radiotracer in a manner similar to LB. Utiliz-
ing an AIT, the initial LB injection can be performed using
a low or moderate volume of injection, if less echelon
nodes are desired, optionally followed by an additional
LB injection with a higher volume (0.8–1.0 ml), if needed,
when better SN delineation is required (more or brighter
SNs). The need for a second injection is based on the view-
ing of sequential dynamic image sets obtained during the
injection process [3-7]. Alternately, only a single high vol-
ume (0.8–1.0 ml) LB injection can be performed for the
study, as a means to simplify the process.
As judiciously mentioned in the case report by Pandey et
al. [1], an additional cause of non-visualization of SNs on
LS is extensive replacement of macrophages in the SNs by
tumor. This can lead to non-visualization of SNs or SNs
that are very faint, if visualized at all [9-11]. However, uti-
lizing the AIT described above with LB injections, will usu-
ally maximize the activity in the SNs (many times more
than with isolated perilesional injections) making the
missed SN on LS images from tumor infiltration (because
it is very faint) less likely.
We perform over half of our studies using a two day pro-
tocol, as this allows more time for the nuclear medicine
department to work with the patient, allows us to take
multiple angle and standing views, perform TBM, and
eliminates the rush to complete the study and print the
images. The two day protocol completely avoids creating
any delays in the surgical schedule related to LS imaging
and TBM, when surgery is performed the morning after
the prior afternoon of imaging. It also allows surgery to be
performed at centers remote from the location performing
LS and TBM.
The often misunderstood [12-14] and least realized bene-
fits of LS and TBM pertains to their ultimate purposes; i.e.
providing a map of the nodes so the surgeons can reduce
the amount of dissection performed during SLNB, thereby
reducing the morbidity of the procedure of SLNB itself.
Even if successful visualization of SNs occurred in only
50% of LS studies, their worth would still be priceless to
these women, as a tool to further reduce morbidity during
SLNB, compared to the potentially higher levels of mor-
bidity when using only the probe without LS or TBM [15-
17].
Fortunately, 94.7%–100% of studies demonstrate SNs
when using optimal techniques of areolar injection and
various levels of LS image acquisition [4-6,17-21], making
these underutilized tools of morbidity reduction applica-
ble to nearly all women undergoing SLNB. This view
appears to be in some ways shared by the authors in the
case report by Pandey et al. [1], as a triple technique con-
sisting of images, probe and dye is still suggested, regard-
less of the misfortunate LS events in the two cases
presented [1].
In this light, the additional utility of standing/sitting
views, with the arm out 90° to the body axis, warrants fur-
ther explanation. These views are the most accurate for
delineating the true number of SNs in the axilla, as they
separate bunched SNs that can appear as a cluster (single
focus) on supine views [3,4,22-28]. They achieve this by
shifting attenuating breast tissues away from the axilla
(more SN counts), allowing the camera to be closer to the
SNs (better SN resolution), shifting the injected activityWorld Journal of Surgical Oncology 2005, 3:56 http://www.wjso.com/content/3/1/56
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away from the axilla (less scatter from injection site to
hide SNs) and by stretching out the lymphatic channels
from their overlapped/bunched state in the spine posi-
tion, to their natural drawn out state when the patient is
standing (better separation between SNs) [3,4,22-28]. By
providing surgeons with a more accurate number and
"relative" orientation of SNs in the woman's body, they
can better plan on how extensive or selective their dissec-
tions are going to be, by more accurately knowing the
number of nodes to expect.
Standing/sitting views are naturally not useful for TBM,
which requires the patient to closely approximate the sur-
gical position to be meaningful, i.e. triangulation per-
formed on supine anterior and oblique views with the
arm out in the 90° surgical position. TBM has been previ-
ously described, and can help provide skin references
regarding SN location for surgeons before incision
[2,3,26,27]. Briefly, the technique consists of the follow-
ing: with the woman supine, back flat against the imaging
table with the arm in the surgical position, an anterior
image is obtained and the SN is noted on the monitor and
a mark (tape, pen marker, electronic) is made on the mon-
itor screen surface over the SN seen on the monitor. A
radioactive point source is brought into the field of view
and moved along the woman's chest until it is positioned
under the reference point on the monitor surface (the tape
or marker point placed earlier on the screen surface while
refreshing/updating the image), at which time the
woman's body is marked with a indelible color marker.
This is repeated in the 45° projection, as lateral views are
blocked by the arm in the surgical position. Triangulation
into the body along the anterior and 45° projection of the
skin surface markings estimates SN location at the crosso-
ver point in the body [2,3,16]. The TBM technique can be
useful in select patients by shorting the time of the initial
probe survey during surgery. It can also help when decay
has reduced the counts in the SNs when using two day
protocols and in obese patients, where effective direction-
ality and sensitivity of the probe are poor at the skin sur-
face because of attenuation and increased distances from
the SNs [2,3,7,27,28]. The technique of TBM will not
accurately delineate the SN position when the breast posi-
tion is different, arm position has shifted, or the patients
torso is rotated differently during surgery compared to the
position during chest marking during LS. These technical
issues must be kept in mind when using the TBM method
as an additional guide during the initial probe survey, and
an agreed upon routine between surgeon and imaging
specialist is required.
None of these techniques require the latest gamma cam-
era equipment, in fact nearly all our studies are performed
on cameras at least 12 years old [2-7]. What is required to
obtain the best LS images and the most accurate TBM, is a
full understanding of the issues and details involved in the
techniques of injection, LS imaging and TBM [2-
7,10,16,17,24,26-28].
Abbreviations
SN Sentinel node
LS Lymphoscintigraphy
SLNB Sentinel lymph node biopsy
TBM Triangulated body marking
AIT Adaptive injection technique
LB LymphoBoost
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